{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:39:50Z","timestamp":1778809190578,"version":"3.51.4"},"reference-count":95,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bbadis.2022.166482","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T02:45:26Z","timestamp":1656989126000},"page":"166482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Reduced hydration regulates pro-inflammatory cytokines via CD14 in barrier function-impaired skin"],"prefix":"10.1016","volume":"1868","author":[{"given":"David","family":"Dolivo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Galiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mustoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Jong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2022.166482_bb0005","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1172\/JCI28521","article-title":"Epidermal barrier formation and recovery in skin disorders","volume":"116","author":"Segre","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2022.166482_bb0010","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1126\/science.1698311","article-title":"CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein","volume":"249","author":"Wright","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2022.166482_bb0015","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cell.2011.09.051","article-title":"CD14 controls the LPS-induced endocytosis of toll-like receptor 4","volume":"147","author":"Zanoni","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2022.166482_bb0020","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1084\/jem.20101111","article-title":"CD14 is a coreceptor of toll-like receptors 7 and 9CD14: coreceptor of TLR7 and TLR9","volume":"207","author":"Baumann","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2022.166482_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005544","article-title":"Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens","volume":"5","author":"Raby","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2022.166482_bb0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fcimb.2013.00032","article-title":"Role of CD14 in host protection against infections and in metabolism regulation","volume":"3","author":"Zanoni","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cytogfr.2019.06.003","article-title":"CD14: biology and role in the pathogenesis of disease","volume":"48","author":"Wu","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbadis.2022.166482_bb0040","series-title":"The Role of Toll-Like Receptor 4 in Infectious and Non Infectious Inflammation","first-page":"57","article-title":"CD14: not just chaperone, but a key-player in inflammation","author":"Gioia","year":"2021"},{"key":"10.1016\/j.bbadis.2022.166482_bb0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1440-1711.2005.01370.x","article-title":"Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells","volume":"83","author":"Jersmann","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1523-1747.2002.01847.x","article-title":"Human keratinocytes express functional CD14 and toll-like receptor 4","volume":"119","author":"Song","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0055","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0168-8278(99)80034-8","article-title":"CD14 expression and production by human hepatocytes","volume":"31","author":"Su","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0060","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.4049\/jimmunol.172.7.4470","article-title":"CD14 is an acute-phase protein","volume":"172","author":"Bas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3748\/wjg.v8.i1.124","article-title":"Lipopolysaccharide induced synthesis of CD14 proteins and its gene expression in hepatocytes during endotoxemia","volume":"8","author":"Li","year":"2002","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034903","article-title":"Effects of hepatocyte CD14 upregulation during cholestasis on endotoxin sensitivity","volume":"7","author":"Chou","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.bbadis.2022.166482_bb0075","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1128\/IAI.66.11.5089-5098.1998","article-title":"Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia","volume":"66","author":"Liu","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2022.166482_bb0080","doi-asserted-by":"crossref","first-page":"36430","DOI":"10.1074\/jbc.M003192200","article-title":"Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes","volume":"275","author":"Pan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2022.166482_bb0085","first-page":"2867","article-title":"The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells","volume":"42","author":"Song","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbadis.2022.166482_bb0090","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1128\/IAI.67.12.6225-6233.1999","article-title":"Increase of CD26\/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components","volume":"67","author":"Nemoto","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2022.166482_bb0095","series-title":"Structural and Functional Differentiation of Sinusoidal Endothelial Cells During Liver Organogenesis in Humans","author":"Couvelard","year":"1996"},{"key":"10.1016\/j.bbadis.2022.166482_bb0100","article-title":"CD14 is a co-receptor for TLR4 in the S100A9-induced pro-inflammatory response in monocytes","volume":"11","author":"He","year":"2016","journal-title":"Plos One"},{"key":"10.1016\/j.bbadis.2022.166482_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2119\/molmed.2012.00306","article-title":"Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14","volume":"19","author":"Kim","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2022.166482_bb0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.matbio.2018.05.006","article-title":"Biglycan is a new high-affinity ligand for CD14 in macrophages","volume":"77","author":"Roedig","year":"2019","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0115","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/glia.22955","article-title":"CD 14 is a key organizer of microglial responses to CNS infection and injury","volume":"64","author":"Janova","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.bbadis.2022.166482_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajpath.2015.09.005","article-title":"S100A8 and S100A9 are induced by decreased hydration in the epidermis and promote fibroblast activation and fibrosis in the dermis","volume":"186","author":"Zhong","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0125","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jid.2016.10.040","article-title":"S100A12 induced in the epidermis by reduced hydration activates dermal fibroblasts and causes dermal fibrosis","volume":"137","author":"Zhao","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0130","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1038\/jid.2014.253","article-title":"Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9","volume":"134","author":"Nikitorowicz-Buniak","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0135","series-title":"Damage-associated Molecular Patterns in Human Diseases","first-page":"151","article-title":"DAMP-promoted efferent innate immune responses in human diseases: inflammation","author":"Land","year":"2020"},{"key":"10.1016\/j.bbadis.2022.166482_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1824624","article-title":"The role of toll-like receptors in skin host defense, psoriasis, and atopic dermatitis","volume":"2019","author":"Sun","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.bbadis.2022.166482_bb0145","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2012.05.162","article-title":"S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin","volume":"423","author":"Lee","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2022.166482_bb0150","first-page":"528","article-title":"S100 proteins in rheumatic diseases, nature reviews","volume":"14","author":"Austermann","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbadis.2022.166482_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aad0286","article-title":"Sodium channel nax is a regulator in epithelial sodium homeostasis","volume":"7","author":"Xu","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2022.166482_bb0160","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/jid.2014.477","article-title":"Hydration status regulates sodium flux and inflammatory pathways through epithelial sodium channel (ENaC) in the skin","volume":"135","author":"Xu","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0165","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/jid.2013.425","article-title":"The expression of proinflammatory genes in epidermal keratinocytes is regulated by hydration status","volume":"134","author":"Xu","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0170","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/exd.13917","article-title":"Imiquimod-induced skin inflammation is relieved by knockdown of sodium channel nax","volume":"28","author":"Zhao","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41374-020-0371-1","article-title":"Knockdown of sodium channel na-x reduces dermatitis symptoms in rabbit skin","volume":"100","author":"Zhao","year":"2020","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2022.166482_bb0180","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/jid.2010.420","article-title":"Epithelial regulation of mesenchymal tissue behavior","volume":"131","author":"Gallant-Behm","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaci.2020.05.048","article-title":"Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis","volume":"147","author":"He","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/exd.14463","article-title":"Aged and young mice differentially respond to tape-stripping in epidermal gene expression","volume":"31","author":"Wen","year":"2022","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0200","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/jcm10020359","article-title":"Skin barrier function in psoriasis and atopic dermatitis: transepidermal water loss and temperature as useful tools to assess disease severity","volume":"10","author":"Montero-Vilchez","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbadis.2022.166482_bb0205","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.burns.2016.04.018","article-title":"Transepidermal water loss measured with the tewameter TM300 in burn scars","volume":"42","author":"Gardien","year":"2016","journal-title":"Burns"},{"key":"10.1016\/j.bbadis.2022.166482_bb0210","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archderm.1996.03890360039008","article-title":"Functional analyses of the stratum corneum in scars: sequential studies after injury and comparison among keloids, hypertrophic scars, and atrophic scars","volume":"132","author":"Suetake","year":"1996","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0923-1811(02)00006-3","article-title":"Functions of the stratum corneum in systemic sclerosis as distinct from hypertrophic scar and keloid functions","volume":"29","author":"Sogabe","year":"2002","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bbadis.2022.166482_bb0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/dth.12339","article-title":"Measurement of transepidermal water loss in localized scleroderma","volume":"29","author":"\u010eur\u010dansk\u00e1","year":"2016","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.bbadis.2022.166482_bb0225","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1002\/jcp.26407","article-title":"Comparative peptidomic profile between human hypertrophic scar tissue and matched normal skin for identification of endogenous peptides involved in scar pathology","volume":"233","author":"Li","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0230","first-page":"41","article-title":"Expression of Notch receptors, ligands and downstream target genes in epidermis of hypertrophic scar","volume":"25","author":"Xia","year":"2009","journal-title":"Zhonghua Zheng Xing Wai Ke Za Zhi"},{"key":"10.1016\/j.bbadis.2022.166482_bb0235","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjd.14844","article-title":"Increased epidermal thickness and abnormal epidermal differentiation in keloid scars","volume":"176","author":"Limandjaja","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/path.1502","article-title":"Hypertrophic scar formation is associated with an increased number of epidermal langerhans cells","volume":"202","author":"Niessen","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0245","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/s41388-018-0509-4","article-title":"ZNF185 is a p63 target gene critical for epidermal differentiation and squamous cell carcinoma development","volume":"38","author":"Smirnov","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2022.166482_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7435621","article-title":"HaCaT cells as a reliable in vitro differentiation model to dissect the Inflammatory\/Repair response of human keratinocytes","volume":"2017","author":"Colombo","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"Suppl 1","key":"10.1016\/j.bbadis.2022.166482_bb0255","first-page":"S46","article-title":"Role of keratinocyte-fibroblast cross-talk in development of hypertrophic scar","volume":"15","author":"Ghahary","year":"2007","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.bbadis.2022.166482_bb0260","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jid.2016.03.022","article-title":"The aldo-keto reductase AKR1B10 is up-regulated in keloid epidermis, implicating retinoic acid pathway dysregulation in the pathogenesis of keloid disease","volume":"136","author":"Jumper","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0265","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/jid.2010.120","article-title":"Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis","volume":"130","author":"Aden","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0270","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/rheumatology\/ken370","article-title":"Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer","volume":"47","author":"Aden","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbadis.2022.166482_bb0275","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1681\/ASN.V1191681","article-title":"Induction of CD14 in tubular epithelial cells during kidney disease","volume":"11","author":"Morrissey","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bbadis.2022.166482_bb0280","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/eji.1830261121","article-title":"Induction of CD14 expression in lpsn, lpsd and tumor necrosis factor receptor-deficient mice","volume":"26","author":"Takakuwa","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0285","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1128\/iai.65.11.4822-4831.1997","article-title":"Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide","volume":"65","author":"Fearns","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2022.166482_bb0290","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1084\/jem.181.3.857","article-title":"Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide","volume":"181","author":"Fearns","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2022.166482_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-8-138","article-title":"Endotoxin and CD14 in the progression of biliary atresia","volume":"8","author":"Chou","year":"2010","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2022.166482_bb0300","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2010.175","article-title":"Renal CD14 expression correlates with the progression of cystic kidney disease","volume":"78","author":"Zhou","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2022.166482_bb0305","doi-asserted-by":"crossref","first-page":"F1034","DOI":"10.1152\/ajprenal.00414.2005","article-title":"Sepsis induces changes in the expression and distribution of toll-like receptor 4 in the rat kidney","volume":"290","author":"El-Achkar","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bbadis.2022.166482_bb0310","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4049\/jimmunol.155.1.316","article-title":"Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide","volume":"155","author":"Camussi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0315","first-page":"441","article-title":"Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS","volume":"10","author":"Bussolati","year":"2002","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbadis.2022.166482_bb0320","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jcb.21639","article-title":"S100A8\/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes","volume":"104","author":"Nukui","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2022.166482_bb0325","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1038\/sj.jid.5700820","article-title":"HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-\u03baB activities","volume":"127","author":"Benedyk","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0330","first-page":"2476","article-title":"Effect of S100A8 and S100A9 on expressions of cytokine and skin barrier protein in human keratinocytes","volume":"20","author":"Kim","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2022.166482_bb0335","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.immuni.2013.11.011","article-title":"S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3","volume":"39","author":"Schonthaler","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2022.166482_bb0340","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clindermatol.2011.08.022","article-title":"Abnormal epidermal barrier in the pathogenesis of psoriasis","volume":"30","author":"Wolf","year":"2012","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0345","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/jid.2014.205","article-title":"Abnormal epidermal barrier recovery in uninvolved skin supports the notion of an epidermal pathogenesis of psoriasis","volume":"134","author":"Ye","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0350","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/1523-1747.ep12582813","article-title":"Stratum corneum structure and function correlates with phenotype in psoriasis","volume":"107","author":"Ghadially","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0355","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.dsi.2015.04.010","article-title":"Psoriasis as a barrier disease","volume":"33","author":"Sano","year":"2015","journal-title":"Dermatol. Sin."},{"key":"10.1016\/j.bbadis.2022.166482_bb0360","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0365","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-0765.2010.01311.x","article-title":"Soluble CD14 induces cytokine release by human oral epithelial cells","volume":"46","author":"Feghali","year":"2011","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.bbadis.2022.166482_bb0370","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-2478(98)00046-7","article-title":"The CD14 molecule participates in regulation of IL-8 and IL-6 release by bronchial epithelial cells","volume":"62","author":"Striz","year":"1998","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbadis.2022.166482_bb0375","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3390\/cells9071689","article-title":"Soluble CD14 induces pro-inflammatory cytokines in rheumatoid arthritis fibroblast-like synovial cells via toll-like receptor 4","volume":"9","author":"Ichise","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2022.166482_bb0380","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1128\/IAI.66.5.2264-2271.1998","article-title":"Soluble CD14 activates monocytic cells independently of lipopolysaccharide","volume":"66","author":"Landmann","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2022.166482_bb0385","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1096\/fj.201600772R","article-title":"Soluble CD14 acts as a DAMP in human macrophages: origin and involvement in inflammatory cytokine\/chemokine production","volume":"31","author":"Leveque","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2022.166482_bb0390","first-page":"G1318","article-title":"LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice, american journal of physiology-gastrointestinal and liver","volume":"290","author":"Isayama","year":"2006","journal-title":"Physiology"},{"key":"10.1016\/j.bbadis.2022.166482_bb0395","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.lfs.2008.07.021","article-title":"Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice","volume":"83","author":"Roncon-Albuquerque","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2022.166482_bb0400","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.4049\/jimmunol.166.7.4737","article-title":"Reduced early alcohol-induced liver injury in CD14-deficient mice","volume":"166","author":"Yin","year":"2001","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bbadis.2022.166482_bb0405","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.41679","article-title":"LBP and CD14, cofactors of toll-like receptors, are essential for low-grade inflammation-induced exacerbation of post-traumatic osteoarthritis","volume":"73","author":"Won","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0410","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fnins.2018.00772","article-title":"Understanding the effects of both CD14-mediated innate immunity and Device\/Tissue mechanical mismatch in the neuroinflammatory response to intracortical microelectrodes","volume":"12","author":"Bedell","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2022.166482_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-51681-0","article-title":"Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis","volume":"9","author":"Ju","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2022.166482_bb0420","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/immunohorizons.2000112","article-title":"Prevention of acute lung injury by a novel CD14-inhibitory receptor activator of the NF-\u03baB ligand peptide in mice","volume":"5","author":"Ju","year":"2021","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.bbadis.2022.166482_bb0425","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.4049\/jimmunol.1400923","article-title":"Recombinant thrombomodulin inhibits lipopolysaccharide-induced inflammatory response by blocking the functions of CD14","volume":"194","author":"Ma","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0430","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/cei.12212","article-title":"VB-201, an oxidized phospholipid small molecule, inhibits CD14-and toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis","volume":"175","author":"Mendel","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0435","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneuroim.2010.06.011","article-title":"An oxidized phospholipid small molecule, constrains CNS autoimmune disease","volume":"226","author":"Mendel","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0440","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s10620-016-4159-5","article-title":"Treatment with oxidized phospholipids directly inhibits nonalcoholic steatohepatitis and liver fibrosis without affecting steatosis","volume":"61","author":"Mendel","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbadis.2022.166482_bb0445","doi-asserted-by":"crossref","first-page":"12337","DOI":"10.1021\/bi901601b","article-title":"Evidence of a specific interaction between new synthetic antisepsis agents and CD14","volume":"48","author":"Piazza","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2022.166482_bb0450","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027421","article-title":"Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis","volume":"100","author":"Henderson","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.bbadis.2022.166482_bb0455","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/01.CCM.0000124870.42312.C4","article-title":"CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14)","volume":"32","author":"Reinhart","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbadis.2022.166482_bb0460","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/346043","article-title":"Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans","volume":"187","author":"Verbon","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbadis.2022.166482_bb0465","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.4049\/jimmunol.166.5.3599","article-title":"IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans","volume":"166","author":"Verbon","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2022.166482_bb0470","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/09680519030090061301","article-title":"An overview of clinical studies in healthy subjects and patients with severe sepsis with IC14, a CD14-specific chimeric monoclonal antibody","volume":"9","author":"Axtelle","year":"2003","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.bbadis.2022.166482_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103039","article-title":"Pharmacological validation of targets regulating CD14 during macrophage differentiation","volume":"61","author":"Jimenez-Duran","year":"2020","journal-title":"EBioMedicine"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922001533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922001533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:11:17Z","timestamp":1760418677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443922001533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":95,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0925443922001533"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166482","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced hydration regulates pro-inflammatory cytokines via CD14 in barrier function-impaired skin","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166482"}}